Government News

WHO published its first Essential Diagnostics List, a catalogue of the tests needed to diagnose the most common conditions as well as a number of global priority diseases.

Government takes obligatory action for collecting data of all tuberculosis patients to ensure proper tuberculosis diagnosis and its management in patients and their contacts and to reduce tuberculosis transmission and  further to address the problems of emergence and spread of Drug Resistant-Tuberculosis.

Government of India brings Tramadol, a synthetic opioid pain killer, under the control of the Narcotic Drugs and Psychotropic Substances (NDPS) Act 1985. Tramadol is also known as ISIS Drug. ISIS militants are known to abuse tramadol to suppress pain and boost strength during injury. International anti-narcotics authorities also called it as fighter drug.

Indian and foreign pharmaceutical associations need amendment in section 146 of Indian patent act 1970 and form 27 for making Indian patenting system more efficient and it will eliminate vague and unnecessary annual working statement disclosures. Indian patent office has invited responses from stake holders and many pharmaceutical industries and association responded in this regards.

Japan continues to be one of the largest pharmaceutical markets in the globe only behind US and China. The country of 12-13 crores population and have greatest potential in pharmaceutical despite difficult demographic landscape. Life expectancy of Japanese population is higher in the world which is almost 80 years for male and 87 years for female. Older people need more medicine and this is the fundamental of pharmaceutical industry in the Japan.

We are living in stem cell era and it is required proper regulation of stem cells in the country. By increasing use of stem cell products, it was required to provide proper guidelines to define new drug under stem cells category. Government have added stem cells as new drugs. They amended rule 122E of the Drugs and Cosmetics (D&C) Rules, 1945 after suggestions from Drug technical advisory board. These rules may be called the Drugs and Cosmetics Amendment Rules, 2018.